These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1024 related articles for article (PubMed ID: 33946010)

  • 41. Lamotrigine drug interactions in combination therapy and the influence of therapeutic drug monitoring on clinical outcomes in paediatric patients.
    Koristkova B; Grundmann M; Brozmanova H; Kacirova I
    Basic Clin Pharmacol Toxicol; 2019 Jul; 125(1):26-33. PubMed ID: 30681278
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006.
    Aagaard L; Nielsen LH; Hansen EH
    Drug Saf; 2009; 32(11):1067-74. PubMed ID: 19810778
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Safety of attention-deficit/hyperactivity disorder medications in children: an intensive pharmacosurveillance monitoring study.
    Ruggiero S; Rafaniello C; Bravaccio C; Grimaldi G; Granato R; Pascotto A; Sportiello L; Parretta E; Rinaldi B; Panei P; Rossi F; Capuano A
    J Child Adolesc Psychopharmacol; 2012 Dec; 22(6):415-22. PubMed ID: 23234585
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of Three Different Data Sources of Adverse Drug Reactions Using Adverse Drug Reaction Data of Fluorouracil for Gastric Cancer as an Example.
    Niu R; Chen Y; Xiang Y; Liu Y; Guo J; Feng B
    Biol Pharm Bull; 2020; 43(10):1476-1480. PubMed ID: 32999157
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Frequent Adverse Drug Reactions, and Medication Groups under Suspicion.
    Dubrall D; Schmid M; Alešik E; Paeschke N; Stingl J; Sachs B
    Dtsch Arztebl Int; 2018 Jun; 115(23):393-400. PubMed ID: 29960607
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spontaneous reporting of adverse reactions related to proton pump inhibitors.
    Dipasquale V; Cicala G; Laganà F; Cutroneo P; Trimarchi G; Spina E; Romano C
    Dig Liver Dis; 2023 May; 55(5):595-600. PubMed ID: 36404233
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adjunctive topiramate enhances the risk of hypothermia associated with valproic acid therapy.
    Knudsen JF; Sokol GH; Flowers CM
    J Clin Pharm Ther; 2008 Oct; 33(5):513-9. PubMed ID: 18834366
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurocognitive Effects of Antiseizure Medications in Children and Adolescents with Epilepsy.
    Besag FMC; Vasey MJ
    Paediatr Drugs; 2021 May; 23(3):253-286. PubMed ID: 33956338
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analyzing excipient-related adverse events in antiseizure drug formulations.
    Ionova Y; Peterson T; Wilson L
    Epilepsy Res; 2022 Aug; 184():106947. PubMed ID: 35661571
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of Adverse Drug Reactions with Carbamazepine and Oxcarbazepine at a Tertiary Care Hospital.
    Lee JE; Min KR; Kim SH; Kim AH; Kim ST
    Yonsei Med J; 2020 Oct; 61(10):875-879. PubMed ID: 32975062
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutic Basis of Generic Substitution of Antiseizure Medications.
    Elmer S; Reddy DS
    J Pharmacol Exp Ther; 2022 May; 381(2):188-196. PubMed ID: 35241634
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monitoring drug safety in Astrakhan, Russia.
    Kirilochev OO; Dorfman IP; Umerova AR
    Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overview of the Safety of Anti-VEGF Drugs: Analysis of the Italian Spontaneous Reporting System.
    Cutroneo PM; Giardina C; Ientile V; Potenza S; Sottosanti L; Ferrajolo C; Trombetta CJ; Trifirò G
    Drug Saf; 2017 Nov; 40(11):1131-1140. PubMed ID: 28585152
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adverse drug reactions reported by consumers for nervous system medications in Europe 2007 to 2011.
    Aagaard L; Hansen EH
    BMC Pharmacol Toxicol; 2013 Jun; 14():30. PubMed ID: 23763896
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
    Jose J; Rao PG
    Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry.
    Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
    Lancet Neurol; 2018 Jun; 17(6):530-538. PubMed ID: 29680205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characteristics of pediatric adverse drug reaction reports in the Japanese Adverse Drug Event Report Database.
    Noda A; Sakai T; Obara T; Miyazaki M; Tsuchiya M; Oyanagi G; Murai Y; Mano N
    BMC Pharmacol Toxicol; 2020 May; 21(1):36. PubMed ID: 32448369
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Trends in Adverse Drug Reactions Among Children: Evidence from Jiangsu Province of China, 2010-2019.
    Xue H; Li M; Fan L; Du W; Zou J
    Paediatr Drugs; 2023 Jan; 25(1):97-114. PubMed ID: 36319935
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacotherapeutic management of seizures in patients with Angleman Syndrome.
    Samanta D
    Expert Opin Pharmacother; 2022 Sep; 23(13):1511-1522. PubMed ID: 35862628
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Language does not come "in boxes": Assessing discrepancies between adverse drug reactions spontaneous reporting and MedDRA® codes in European Portuguese.
    Inácio P; Airaksinen M; Cavaco A
    Res Social Adm Pharm; 2015; 11(5):664-74. PubMed ID: 25596069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.